L-OLIGONUCLEOTIDE INHIBITORS OF POLYCOMB REPRESSIVE COMPLEX 2 (PRC2)

摘要

The present invention contemplates a method for the treatment of cancer comprising L-nucieic acid. The present invention contemplates a method for the treatment of cancer comprising guanosine-rich L-oligonucleotides. The present invention also relates to Polycomb Repressive Complex 2 (PRC 2) 1, -oligonucleotide inhibitors and their use for the treatment of cancer and other conditions associated with aberrant PRC2 methyl transferase activity.